Results 191 to 200 of about 371,080 (288)

Myocardial metabolic remodeling in human end-stage ischemic and non-ischemic cardiomyopathy. [PDF]

J Mol Cell Cardiol
Zhou H, Christopher CJ, Jones K, Pla MM, Gross RT, Esmailian G, Campagna SR, Bowles DE, Chen W.   +8 more
europepmc   +1 more source

Long‐Term Cardiovascular Outcomes Following New‐Onset Arrhythmias During Pregnancy

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Arrhythmias during pregnancy are increasingly prevalent and associated with acute adverse cardiovascular outcomes, yet their long‐term cardiovascular implications remain poorly defined. To address this gap, we conducted a large population‐based study to evaluate 5‐year cardiovascular outcomes following incident arrhythmias during ...
Sanya Dhama, Yong Hao Yeo, Mohammed Uddin, Rhea Dhama, Kamala P. Tamirisa   +4 more
wiley   +1 more source

Post Pacing Interval Following Failed Anti-Tachycardia Pacing Predicts Epicardial Ventricular Tachycardia Circuits in Patients With Non-Ischemic Cardiomyopathy. [PDF]

J Cardiovasc Electrophysiol
Kong N, Goodyear E, Yang S, Waks J, Michaud G, Maher T, d'Avila A.   +6 more
europepmc   +1 more source

Safety and Performance of INVICTA DF4 Ventricular Defibrillation Lead: Results From APOLLO Prospective Multicenter Study

Pacing and Clinical Electrophysiology, EarlyView.
Abstract Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte, Juan Gabriel Martínez, Mário M. Oliveira, Alberto Barrera, Maite Izquierdo, Cosimo Mandurino, Maria Emilce Trucco, José Juan García Salvador, Antoine Dompnier, Frédéric Jean, Pablo J. Sánchez Millán, Carsten Israel, Maria Martino, Pedro Marques   +13 more
wiley   +1 more source

Determinants, risk score, and prognostic implications of left ventricular thrombus in ischemic cardiomyopathy assessed by cardiac magnetic resonance: a retrospective cohort study. [PDF]

Ann Med
Aramcharoen C, Buraphat P, Wanitanantakun T, Tongsai S, Kaolawanich Y.   +4 more
europepmc   +1 more source

Navigating the Zero Fluoroscopy Frontier: Current Tools, Evidence and Future Directions in Electrophysiology Procedures

Pacing and Clinical Electrophysiology, EarlyView.
Graphical Abstract ABSTRACT Fluoroscopy has traditionally been the mainstay imaging technique for guidance during electrophysiology (EP) ablation procedures. The numerous disadvantages associated with radiation exposure for both operators and patients have created the need for zero‐fluoroscopy (ZF) approaches. Today, electrophysiologists have access to
Dimitrios Kotzadamis, Georgios Giannopoulos, Vaios Schismenos, Alexandros Evangeliou, Prokopios Mamolis, Antonios Antoniadis, Vassilios Vassilikos   +6 more
wiley   +1 more source

The Contemporary Role of Cardiovascular Magnetic Resonance in Ischemic Cardiomyopathy. [PDF]

J Clin Med
Widyawati DG, Teo LLS, Ong CC, Houdmont M, Chai P, Sia CH.   +5 more
europepmc   +1 more source

First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Nibras Soubh, Bernhard C. Danner, Ulrich Krause, Matthias J. Müller, Markus Zabel, Gerd Hasenfuß, Constanze Schmidt, Helge Haarmann, Eva Rasenack, Leonard Bergau   +9 more
wiley   +1 more source

Semaglutide augments vascular proliferation and cardiac performance in a large animal model of ischemic cardiomyopathy. [PDF]

Am J Physiol Heart Circ Physiol
Muir KC, Stone C, Harris DD, Kanuparthy M, Broadwin M, Hamze J, Feng J, Sellke FW.   +7 more
europepmc   +1 more source

Inpatient Cardiac Resynchronization Therapy During Heart Failure Hospitalization: A Distinct High‐Risk Phenotype

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The role of cardiac resynchronization therapy (CRT) during hospitalization for heart failure (HFH) is uncertain, because hospitalized patients were routinely excluded from landmark CRT trials. Despite this, CRT implantation during HFH is common.
Oliver Rees, James Dargan, Jemima Weir, Robin Ray, Giuseppe Rosano, Fadi Johura   +5 more
wiley   +1 more source